Arbovirus Testing Market Size - By Test Type (ELISA-based Tests, RT-PCR Based Tests), By End-use (Public Health Laboratory, Hospitals, Diagnostic Centers) – Global Forecast to 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationArbovirus Testing Market Size - By Test Type (ELISA-based Tests, RT-PCR Based Tests), By End-use (Public Health Laboratory, Hospitals, Diagnostic Centers) – Global Forecast to 2032
Arbovirus Testing Market Size
Arbovirus Testing Market size was valued at more than USD 1 billion in 2022 and is projected to reach over USD 1.9 billion by 2032 owing to rising prevalence rate of arthropod-borne viral diseases.
Arbovirus testing encompasses the diagnostic tests and related products used for the detection and identification of arboviruses. Arboviruses also known as arthropod-borne viruses is a group of viruses transmitted to humans primarily through the bites of infected ticks, mosquitoes, or other arthropods. These viruses can cause a wide range of diseases, including dengue fever, Zika virus infection, West Nile fever, and chikungunya, among others. Growing need for accurate and timely diagnosis of arbovirus infections to guide appropriate patient management and public health interventions will drive the overall industry growth potential.
Also, rising incidence of arthropod-borne viral diseases, advancements in diagnostic technologies, and government initiatives aimed at controlling and preventing arbovirus outbreaks are few aspects propelling market demand.
Growing research and development as well as adoption of advanced arbovirus testing technologies to enhance surveillance, outbreak response, and disease prevention strategies by several governments, health organizations, and researchers to combat arbovirus outbreak will boost market growth potential. For instance, in March 2022, World Health Organization (WHO) introduced global arbovirus initiative to combat emerging and re-emerging arboviruses having epidemic and pandemic potential in collaboration with the Immunization, Vaccines and Biologicals Department and the Department of Control of Neglected Tropical Diseases. This initiative aimed towards preparedness, monitor risk, detection and response, pandemic prevention and building a coalition of partners.
Further, continuous advancements in technologies such as molecular diagnostics, serological assays, and point-of-care testing for rapid and accurate detection of arboviruses leading to improved patient outcomes and public health interventions will thereby offer lucrative growth opportunities to the arbovirus testing market.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Arbovirus Testing Market Size in 2022 | USD 1 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 5.8% |
| 2032 Value Projection | USD 1.9 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 146 |
| Tables, Charts & Figures | 192 |
| Segments covered | Test Type, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the arbovirus testing market. Owing to focus of healthcare institutions and resources moved to combatting the pandemic, testing and management of arbovirus infections became challenging. Surveillance and testing for arboviral infections were hampered due to overburdened healthcare systems and limited resources. Outbreak detection and response methods were redirected to COVID-19, causing delayed arbovirus testing. However, the pandemic highlighted the necessity of diagnostic testing and monitoring in the prevention and control of infectious diseases.
Arbovirus Testing Market Trends
The rising incidence of arbovirus infections such as dengue fever and zika virus infection due to climate change, urbanization and global travel are some of the major factors further augmenting the market expansion. For instance, according to the World Health Organization (WHO), 50-100 million cases of dengue fever, 500,000 cases of dengue haemorrhagic fever/ dengue shock syndrome and more than 20 000 deaths occur each year. This rise in arbovirus infections creating demand for accurate and timely diagnostic testing to facilitate early detection and appropriate patient management.
The surge in arbovirus cases leads to increasing focus on surveillance, prevention, and control measures, this will further accelerate the need for reliable and efficient arbovirus testing solutions. As a result, the market will experience substantial growth with advancements in diagnostic technologies and the development of new testing methods to meet the rising demand.
Arbovirus Testing Test Market Analysis
When it comes to testing for arboviruses, one of the most common methods is the ELISA test. ELISA tests have been a hit in the market, raking in over 530 million dollars in 2022. They're still going strong, and experts predict they'll keep growing in the future. Why are ELISA tests so popular? A lot of it has to do with all the research and new technologies that have been poured into making them better. Scientists have been working hard to improve how sensitive and accurate ELISA tests are, and they've also come up with new multiplex tests that can check for multiple viruses at once. These improvements have made ELISA tests much more efficient and cost-effective, which is why they're expected to continue dominating the market for a while.
Also, ELISA-based tests utilize in assessing the efficacy of vector control measures, identifying high-risk areas, and guiding targeted interventions that will bolster segment demand. Further, High investments in arbovirus surveillance programs and the availability of accurate and accessible ELISA-based tests are anticipated to propel segment revenue size.
Human-Friendly Version When it comes to testing for viruses that are spread by insects (arboviruses), the market is divided into different types of users, such as hospitals, clinics, and government labs. Out of these, government labs had the biggest slice of the pie in 2022. And experts think that this trend is going to continue, with a solid growth rate of around 5.6% over the next few years. The reason for this growth is simplemore and more countries are setting up government labs to test for these viruses. Plus, these labs are getting better at detecting viruses thanks to new technologies like rapid molecular tests and high-powered sequencing machines. This makes people more likely to go to government labs for arbovirus testing, which is pushing the market in that direction.
Further, Public health laboratories are actively collaborating with research institutions, diagnostic companies, and public health agencies to enhance their capabilities in arbovirus testing to promote knowledge sharing, standardization of testing protocols, and the development of new technologies leading to improved testing accuracy, efficiency, and harmonization across different laboratory settings. Such technological advancements will drive the public health laboratories growth potential.
U.S. arbovirus testing market accounted for over USD 400 million in 2022 and is estimated to witness substantial market growth over the forecast period. The surge in incidence and prevalence of arbovirus diseases and booming geriatric population that are highly prone to viral diseases in the country are few factors accelerating market growth.
Furthermore, surge in point of care molecular diagnostics among clinical facilities, well-established healthcare infrastructure, growing R&D expenditures, high usage of sophisticated diagnostic tests and increase in healthcare spending will positively influence the market in the U.S. Also, establishment of comprehensive surveillance programs, strengthening of laboratory networks and the development of integrated response strategies to minimize arbovirus diseases will boost market demand in the U.S.
Arbovirus Testing Market Share
Some of the notable key industry players operating in the arbovirus testing market include
- Agilent Technologies Inc.
- Thermo Fisher Scientific
- NovaTec Immundiagnostica GmbH
- Euroimmun AG
- Abbott Laboratories
- DiaSorin SpA
- Bio-Rad
- Fluke Biomedical
- Copley Scientific
- Distek
- Becton
- Dickinson and Compan
- Merck KGaA
- F.Hoffmann La Roche Ltd.
- Siemens Healthineers AG
- QIAGEN N.V.
. These market participants are implementing several growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development & launches to broaden their product portfolio as well as gain a competitive edge over others.
Arbovirus Testing Industry News
- In July 2022, Mylab announced launch of PathoDetect Extended Monsoon Fever Panel, a multiplex assay RT-PCR test kit for several monsoon disorders such as zika, malaria, dengue among others. These compact kits provide accurate results within 2 hours and also offers mass testing. This launch offered competitive edge to the company in the significant market.
- In May 2022, Anitoa System introduced a portable RT-PCR molecular test in the U.S. This test kit comprised of Maverick qPCR instrument and used in detection of arbovirus disease especially dengue. Such product launches broadened company’s offerings in this significant market.
Arbovirus testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Test Type (USD Million)
- ELISA-based tests
- RT-PCR based tests
- Others
By End-use (USD Million)
- Hospitals
- Diagnostic Centers
- Public Health Laboratory
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Belgium
- The Netherlands
- Switzerland
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Singapore
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy